Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Economic evaluation of pharmaceuticals: science or marketing?

Literature DB >> 10147035

Economic evaluation of pharmaceuticals: science or marketing?

M F Drummond¹.

Abstract

Mesh：

Year: 1992 PMID： 10147035 DOI： 10.2165/00019053-199201010-00004

Source DB: PubMed Journal: Pharmacoeconomics ISSN： 1170-7690 Impact factor: 4.981

× No keyword cloud information.

8 in total

Review 1. The use of QALYs in health care decision making.

Authors: G Loomes; L McKenzie
Journal: Soc Sci Med Date: 1989 Impact factor: 4.634

2. Farewell to promoting goodbuys?

Authors:
Journal: Lancet Date: 1991-08-17 Impact factor: 79.321

3. Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

Authors: A L Hillman; J M Eisenberg; M V Pauly; B S Bloom; H Glick; B Kinosian; J S Schwartz
Journal: N Engl J Med Date: 1991-05-09 Impact factor: 91.245

4. Economic analysis alongside clinical trials. Revisiting the methodological issues.

Authors: M F Drummond; L Davies
Journal: Int J Technol Assess Health Care Date: 1991 Impact factor: 2.188

5. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.

Authors: D Y Graham; N M Agrawal; S H Roth
Journal: Lancet Date: 1988-12-03 Impact factor: 79.321

6. Quality-adjusted life years, utility theory, and healthy-years equivalents.

Authors: A Mehrez; A Gafni
Journal: Med Decis Making Date: 1989 Apr-Jun Impact factor: 2.583

7. Standardizing methodologies for economic evaluation in health care. Practice, problems, and potential.

Authors: M Drummond; A Brandt; B Luce; J Rovira
Journal: Int J Technol Assess Health Care Date: 1993 Impact factor: 2.188

8. The effect of hypotensive drugs on the quality of life.

Authors: S J Jachuck; H Brierley; S Jachuck; P M Willcox
Journal: J R Coll Gen Pract Date: 1982-02

8 in total

22 in total

Review 1. Conflict of interest in industry-sponsored economic evaluations: real or imagined?

Authors: M Barbieri; M F Drummond
Journal: Curr Oncol Rep Date: 2001-09 Impact factor: 5.075

2. Using economic evaluations to make formulary coverage decisions. So much for guidelines.

Authors: A H Anis; Y Gagnon
Journal: Pharmacoeconomics Date: 2000-07 Impact factor: 4.981

3. A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?

Authors: M F Drummond
Journal: Pharmacoeconomics Date: 1998-07 Impact factor: 4.981

4. Applied pharmacoeconomics. When can publication be legitimately withheld?

Authors: G C Yee; A L Hillman
Journal: Pharmacoeconomics Date: 1997-11 Impact factor: 4.981

5. Cost-effectiveness analysis: obstacles to standardisation and its use in regulating pharmaceuticals.

Authors: B R Luce
Journal: Pharmacoeconomics Date: 1993-01 Impact factor: 4.981

6. Is there a need for an independent centre for pharmacoeconomics in the UK?

Authors: T Walley; R T Edwards
Journal: Pharmacoeconomics Date: 1994-02 Impact factor: 4.981

Review 7. Economic evaluation of pharmaceuticals: a European perspective.

Authors: M Drummond; F Rutten; A Brenna; C G Pinto; B Horisberger; B Jönsson; C Le Pen; J Rovira; M G von der Schulenburg; H Sintonen
Journal: Pharmacoeconomics Date: 1993-09 Impact factor: 4.981

8. Health economics in primary care in the UK: containment of drug costs.

Authors: T Walley; R T Edwards
Journal: Pharmacoeconomics Date: 1993-02 Impact factor: 4.981

9. The changing healthcare environment: socioeconomic evaluation of drug therapy.

Authors: D B Evans
Journal: Pharmacoeconomics Date: 1992-01 Impact factor: 4.981

10. Economic evaluation of pharmaceuticals: a critical appraisal of seven studies on cholesterol-lowering agents.

Authors: P Gazzaniga; L Garattini
Journal: Pharmacoeconomics Date: 1992-10 Impact factor: 4.981